References
- Spooner N . Bioanalysis: 10 years of progress. Bioanalysis11(7), 547–549 (2019).
- Dormer L . Celebrating 10 years of publishing Bioanalysis. Bioanalysis11(7), 551–553 (2019).
- Bioanalysis Zone. https://www.bioanalysis-zone.com/
- Maundrell N . Celebrating the collaboration of Bioanalysis and Bioanalysis Zone. Bioanalysis11(7), 555–556 (2019).
- Patel SR , BryanP, SpoonerN, TimmermanP, WickremsinheE. Microsampling for quantitative bioanalysis, an industry update: output from an AAPS/EBF survey. Bioanalysis11(7), 619–628 (2019).
- Timmerman P . A note from the European Bioanalysis Forum (EBF). Bioanalysis11(7), 561–562 (2019).
- Jin F , TangD, DongK, ZhongD. New development of the Chinese bioanalytical landscape and update of the China Bioanalysis Forum (CBF). Bioanalysis11(7), 567–569 (2019).
- Igarashi H , KosekiN, ArakawaT. The Japan Bioanalysis Forum (JBF): the past 8 years and future perspectives. Bioanalysis11(7), 611–617 (2019).
- Marcelín-Jiménez G . The 10-year bioanalysis challenge in Mexico. Bioanalysis11(7), 575–577 (2019).
- Garofolo W , SavoieN. Looking beyond the WRIB Decennial Index of the White Papers in Bioanalysis. Bioanalysis11(7), 563–565 (2019).
- Islam R , KarS, RitzénH. Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis. Bioanalysis11(7), 645–653 (2019).
- Briscoe C . Assessing stability in bioanalysis: reflections on the last 10 years. Bioanalysis11(7), 579–582 (2019).
- MacNeill R . Instrumental and technical evolution over the past decade in bioanalysis. Bioanalysis11(7), 601–606 (2019).
- van der Merbel N . Protein quantification by LC–MS: a decade of progress through the pages of Bioanalysis. Bioanalysis11(7), 629–644 (2019).
- Hawthorne G , HendersonN, HölttäM, StovoldC, WåhlanderÅ, WilsonA. Bioanalysis – but not as we knew it: an AstraZeneca perspective of the last 10 years evolution to meet a diversifying portfolio. Bioanalysis11(7), 595–599 (2019).
- Stevenson LF . Evolving our thinking on biomarker assay validation – are we ready for the next leap?Bioanalysis11(7), 571–573 (2019).
- Yu C , BashawED. Regulatory perspective of biomarker bioanalysis during drug development. Bioanalysis11(7), 607–610 (2019).
- Haidar S . Regulatory efforts in response to a decade of scientific advancement in bioanalytical methods. Bioanalysis11(7), 583–586 (2019).
- Lowes S , BrownM. Bioanalytical method validation guidance language and a decade of progress. Bioanalysis11(7), 587–593 (2019).
- Allen K . Perspectives on gender parity in bioanalysis: an interview with Katryn Allen. Bioanalysis 11(7), 655–656 (2019).
- Borenstein MR . Perspectives on gender parity in bioanalysis: an interview with Michael R Borenstein. Bioanalysis 11(7), 657–658 (2019).
- Briscoe C . Perspectives on gender parity in bioanalysis: an interview with Chad Briscoe. Bioanalysis 11(7), 659–660 (2019).
- Cape S . Perspectives on gender parity in bioanalysis: an interview with Stephanie Cape. Bioanalysis11(7), 661–662 (2019).
- DeSilva B . Perspectives on gender parity in bioanalysis: an interview with Binodh DeSilva. Bioanalysis. 11(7), 663–664 (2019).
- Needham S . Perspectives on gender parity in bioanalysis: an interview with Shane Needham. Bioanalysis11(7), 665–666 (2019).
- Patel S . Perspectives on gender parity in bioanalysis: an interview with Shefali Patel. Bioanalysis11(7), 667–669 (2019).
- Sims A . Perspectives on gender parity in bioanalysis: an interview with Atreyee Sims. Bioanalysis11(7), 671–672 (2019).
- Stevenson L . Perspectives on gender parity in bioanalysis: an interview with Lauren Stevenson. Bioanalysis11(7), 673–674 (2019).
- Summerfield S . Perspectives on gender parity in bioanalysis: an interview with Scott Summerfield. Bioanalysis11(7), 675–676 (2019).
- Tanna N . Perspectives on gender parity in bioanalysis: an interview with Nikunj Tanna. Bioanalysis11(7), 677–678 (2019).
- Hill H , SpoonerN. Reflecting on Bioanalysis with the Senior Editors. Bioanalysis11(7), 557–560 (2019).